Germ cell tumours are common among young males with excellent outcomes even in advanced stages. Despite a superb curability rate, treatment-related side effects and complications affect the quality of life. We report a case where Cisplatin-based chemotherapy, the backbone for germ cell tumours treatment, led to ischemic insult. The purpose is to highlight the importance of keeping the incidence of ischemic events following cisplatin-based chemotherapy in differentials for effective management.
Key words: Cisplatin, Brain Ischemia, Stroke, Germ Cell Tumor, Seminoma, Peripheral Nervous System Diseases, Ischemic Stroke
|
